Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
Current Treatment Options in Oncology
|
June 15, 2023
Recurrent/Metastatic Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Heading?
Juan Jose Juarez-Vignon Whaley, Michelle Afkhami, Mykola Onyshchenko, et al.
International Journal of Surgical Pathology
|
May 13, 2017
Salivary Gland Secretory Carcinoma With High-Grade Transformation, CDKN2A/B Loss, Distant Metastasis, and Lack of Sustained Response to Crizotinib
Nicole A Cipriani, Elizabeth A Blair, Joshua Finkle, et al.
Oncotarget
|
November 17, 2016
Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials
Ricardo Costa, Benedito A Carneiro, Mark Agulnik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2008
The potential predictive value of cyclooxygenase-2 expression and increased risk of gastrointestinal hemorrhage in advanced non-small cell lung cancer patients treated with erlotinib and celecoxib
Mary J Fidler, Athanassios Argiris, Jyoti D Patel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 3, 2009
Single-agent versus combination chemotherapy in patients with advanced non-small cell lung cancer and a performance status of 2: prognostic factors and treatment selection based on two large randomized clinical trials
Rogerio Lilenbaum, Victoria M Villaflor, Corey Langer, et al.
Cold Spring Harbor Molecular Case Studies
|
April 28, 2022
Prolonged response to checkpoint inhibitor therapy in two metastatic mucoepidermoid salivary gland carcinoma cases: a research report
Rebecca R Pharaon, Thomas Gernon, Sue Chang, et al.
Journal of Carcinogenesis
|
December 10, 2013
O-6-methylguanine-deoxyribonucleic acid methyltransferase methylation enhances response to temozolomide treatment in esophageal cancer
Rifat Hasina, Mosmi Surati, Ichiro Kawada, et al.
Oncotarget
|
December 29, 2016
Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application
Young Kwang Chae, Keerthi Ranganath, Peter S Hammerman, et al.
Head & Neck Oncology
|
July 28, 2011
Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies
Aaron W Pederson, Joseph K Salama, Daniel J Haraf, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 3, 2007
The prognostic value of chromosome 7 polysomy in non-small cell lung cancer patients treated with gefitinib
Lela E Buckingham, John S Coon, Larry E Morrison, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
Current Treatment Options in Oncology
|
June 15, 2023
Recurrent/Metastatic Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Heading?
Juan Jose Juarez-Vignon Whaley, Michelle Afkhami, Mykola Onyshchenko, et al.
International Journal of Surgical Pathology
|
May 13, 2017
Salivary Gland Secretory Carcinoma With High-Grade Transformation, CDKN2A/B Loss, Distant Metastasis, and Lack of Sustained Response to Crizotinib
Nicole A Cipriani, Elizabeth A Blair, Joshua Finkle, et al.
Oncotarget
|
November 17, 2016
Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials
Ricardo Costa, Benedito A Carneiro, Mark Agulnik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2008
The potential predictive value of cyclooxygenase-2 expression and increased risk of gastrointestinal hemorrhage in advanced non-small cell lung cancer patients treated with erlotinib and celecoxib
Mary J Fidler, Athanassios Argiris, Jyoti D Patel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 3, 2009
Single-agent versus combination chemotherapy in patients with advanced non-small cell lung cancer and a performance status of 2: prognostic factors and treatment selection based on two large randomized clinical trials
Rogerio Lilenbaum, Victoria M Villaflor, Corey Langer, et al.
Cold Spring Harbor Molecular Case Studies
|
April 28, 2022
Prolonged response to checkpoint inhibitor therapy in two metastatic mucoepidermoid salivary gland carcinoma cases: a research report
Rebecca R Pharaon, Thomas Gernon, Sue Chang, et al.
Journal of Carcinogenesis
|
December 10, 2013
O-6-methylguanine-deoxyribonucleic acid methyltransferase methylation enhances response to temozolomide treatment in esophageal cancer
Rifat Hasina, Mosmi Surati, Ichiro Kawada, et al.
Oncotarget
|
December 29, 2016
Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application
Young Kwang Chae, Keerthi Ranganath, Peter S Hammerman, et al.
Head & Neck Oncology
|
July 28, 2011
Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies
Aaron W Pederson, Joseph K Salama, Daniel J Haraf, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 3, 2007
The prognostic value of chromosome 7 polysomy in non-small cell lung cancer patients treated with gefitinib
Lela E Buckingham, John S Coon, Larry E Morrison, et al.
Page
of 5